DK461877A - N-substituerede lactamer fremgangsmaade til deres fremstilling samt farmaceutiske kompositioner indeholdende disse forbindelser - Google Patents

N-substituerede lactamer fremgangsmaade til deres fremstilling samt farmaceutiske kompositioner indeholdende disse forbindelser

Info

Publication number
DK461877A
DK461877A DK461877A DK461877A DK461877A DK 461877 A DK461877 A DK 461877A DK 461877 A DK461877 A DK 461877A DK 461877 A DK461877 A DK 461877A DK 461877 A DK461877 A DK 461877A
Authority
DK
Denmark
Prior art keywords
compounds
procedure
preparation
pharmaceutical compositions
compositions containing
Prior art date
Application number
DK461877A
Other languages
English (en)
Inventor
L Rodriguez
L Marchal
Original Assignee
Ucb Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ucb Sa filed Critical Ucb Sa
Publication of DK461877A publication Critical patent/DK461877A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24—Oxygen or sulfur atoms
    • C07D207/26—2-Pyrrolidones
    • C07D207/263—2-Pyrrolidones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms
    • C07D207/27—2-Pyrrolidones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms with substituted hydrocarbon radicals directly attached to the ring nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/02—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D223/06—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D223/08—Oxygen atoms
    • C07D223/10—Oxygen atoms attached in position 2

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Peptides Or Proteins (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
DK461877A 1976-10-22 1977-10-17 N-substituerede lactamer fremgangsmaade til deres fremstilling samt farmaceutiske kompositioner indeholdende disse forbindelser DK461877A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB43934/76A GB1539817A (en) 1976-10-22 1976-10-22 N-substituted lactams

Publications (1)

Publication Number Publication Date
DK461877A true DK461877A (da) 1978-04-23

Family

ID=10431009

Family Applications (1)

Application Number Title Priority Date Filing Date
DK461877A DK461877A (da) 1976-10-22 1977-10-17 N-substituerede lactamer fremgangsmaade til deres fremstilling samt farmaceutiske kompositioner indeholdende disse forbindelser

Country Status (27)

Country Link
US (1) US4162325A (da)
JP (1) JPS5839148B2 (da)
AT (1) AT352742B (da)
BE (1) BE859925A (da)
BG (1) BG28413A3 (da)
CA (1) CA1095040A (da)
CH (1) CH625214A5 (da)
CS (1) CS200231B2 (da)
CY (1) CY1037A (da)
DD (1) DD131930A5 (da)
DE (1) DE2747369A1 (da)
DK (1) DK461877A (da)
ES (1) ES463424A1 (da)
FI (1) FI66600C (da)
FR (1) FR2368474B1 (da)
GB (1) GB1539817A (da)
HK (1) HK2380A (da)
HU (1) HU174864B (da)
IL (1) IL53171A (da)
KE (1) KE3013A (da)
MY (1) MY8000264A (da)
NL (1) NL7711414A (da)
PL (1) PL110679B1 (da)
SE (1) SE425782B (da)
SU (2) SU805945A3 (da)
YU (1) YU251977A (da)
ZA (1) ZA776260B (da)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0005689B1 (fr) * 1978-05-08 1981-03-18 U C B, S.A. Nouveaux acides lactame-N-acétiques et leurs amides, leurs procédés de préparation et compositions thérapeutiques
EP0115472A3 (de) * 1983-01-27 1985-10-02 Ciba-Geigy Ag Pyrrolidinonderivate und Verfahren zu ihrer Herstellung
EP0115473A3 (de) * 1983-01-27 1987-01-21 Ciba-Geigy Ag Substituierte Pyrrolidinonderivate und Verfahren zu ihrer Herstellung
IT1190378B (it) * 1985-06-21 1988-02-16 Isf Spa Derivati pirrolidonici
US5118811A (en) * 1989-04-13 1992-06-02 Japan Tobacco Inc. Amino acid derivatives possessing prolyl endopeptidase-inhibitory activities
US5206386A (en) * 1991-03-20 1993-04-27 Isp Investments Inc. Controlled release N-substituted pyrrolidone esters and process for the use thereof
DE4308034A1 (de) * 1993-03-13 1994-09-15 Cassella Ag Neue Heterocyclen, ihre Herstellung und ihre Verwendung
US5658940A (en) * 1995-10-06 1997-08-19 Celgene Corporation Succinimide and maleimide cytokine inhibitors
US5914332A (en) * 1995-12-13 1999-06-22 Abbott Laboratories Retroviral protease inhibiting compounds
CN114685342B (zh) * 2020-12-25 2024-05-10 长沙博源医疗科技有限公司 一种左乙拉西坦衍生物、免疫原、抗左乙拉西坦特异性抗体及其制备方法与应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3121723A (en) * 1955-11-02 1964-02-18 Sterling Drug Inc Lower alkyl n-(tertiary-amino-lower-alkyl) lower alkamates and quaternary ammonium salts thereof
GB1039113A (en) * 1964-08-06 1966-08-17 Ucb Sa New n-substituted lactams
NL7407140A (nl) * 1974-03-07 1975-09-09 Jose Maria Espinos Taya En Jos Werkwijze voor de bereiding van een n-gesub- stitueerd pyrrolidon.
AT360980B (de) * 1976-01-14 1981-02-10 Pliva Pharm & Chem Works Verfahren zur herstellung von n-alkylamiden des 2-oxo-1-pyrrolidins

Also Published As

Publication number Publication date
SE7711667L (sv) 1978-04-23
SE425782B (sv) 1982-11-08
FI66600B (fi) 1984-07-31
YU251977A (en) 1983-01-21
DD131930A5 (de) 1978-08-09
DE2747369A1 (de) 1978-04-27
JPS5353649A (en) 1978-05-16
FI66600C (fi) 1984-11-12
KE3013A (en) 1980-02-01
SU937450A1 (ru) 1982-06-23
ATA749677A (de) 1979-03-15
HU174864B (hu) 1980-03-28
PL110679B1 (en) 1980-07-31
SU805945A3 (ru) 1981-02-15
PL201601A1 (pl) 1979-01-29
FR2368474B1 (fr) 1980-08-08
AT352742B (de) 1979-10-10
ZA776260B (en) 1978-07-26
IL53171A0 (en) 1977-12-30
CS200231B2 (en) 1980-08-29
CY1037A (en) 1980-08-01
IL53171A (en) 1982-02-28
HK2380A (en) 1980-01-25
DE2747369C2 (da) 1987-11-12
NL7711414A (nl) 1978-04-25
BG28413A3 (en) 1980-04-15
FI773069A (fi) 1978-04-23
US4162325A (en) 1979-07-24
CH625214A5 (da) 1981-09-15
CA1095040A (en) 1981-02-03
ES463424A1 (es) 1978-07-16
FR2368474A1 (da) 1978-05-19
JPS5839148B2 (ja) 1983-08-27
MY8000264A (en) 1980-12-31
BE859925A (fr) 1978-04-20
GB1539817A (en) 1979-02-07

Similar Documents

Publication Publication Date Title
GB1545292A (en) Vial stopper
IL60510A (en) Derivatives of n-(mercaptoalkylcarbonyl)glycine,processes for their preparation and pharmaceutical compositions containing them
IL51297A0 (en) Proline derivatives and related compounds pharmaceutical compositions containing the same and process for the preparation thereof
DK2677A (da) Fremgangsmade til fremstilling af 1-(substitueret amino)-alkanoyl-2-(dibenzoxazepin-10-carbonyl)-hydraziner samt derivater deraf
HU179058B (en) Herbicide compositions containing n-substituted 2-pyrrolidinone derivatives and process for preparing the active substances thereof
DK77580A (da) Fremgangsmaade til fremstilling af beta-lactamholdige forbindelser isaer penemcarboxylsyrer
IL53208A0 (en) Pyrrolidine and piperidine derivatives processes for the preparation thereof and pharmaceutical or veterinary compositions containing the same
DK46478A (da) N-substituerede halogenacetanilider fremgangsmaade til deres fremstilling samt deres anvendelse som herbicider
DK572578A (da) 4-spectinomycin og dets fyiologisk acceptable salte fremgangsmaade til deres fremstilling samt kompositioner indeholdende disse forbindelser
DK461877A (da) N-substituerede lactamer fremgangsmaade til deres fremstilling samt farmaceutiske kompositioner indeholdende disse forbindelser
DK538677A (da) Isoxazolderivater fremgangsmaade til deres fremstilling og midler indeholdende disse forbindelser
DK94880A (da) D-2-hydroxy-4-methylmercaptosmoersyrederivater fremgangsmaade til fremstilling heraf samt anvendelse heraf
DK404879A (da) Kortikoid-21-sulfopropionater og deres salte fremgangsmaade til deres fremstilling og farmaceutiske praeparater indeholdende disse forbindelser
DK489378A (da) 6-oxygenerede-3,20-dioxopregnanderivater samt fremgangsmaade til fremstilling der af og farmaceutiske kompositioner indeholdende disse
DK363280A (da) Fremgangsmaade til fremstilling af n-substituerede piperazinderivater
DK288880A (da) Acylurinstoffer insekticide midler indeholdende disse forbindelser samt fremgangsmaade til deres fremstilling
DK211380A (da) Thiazolylidenoxypropionitriler insekticide midler indeholdende disse forbindelser samt fremgangsmaader til deres fremstilling
DK320379A (da) Immunstimulerende n-substituerede aziridin-2-carbonsyrederivater fremgangsmaade til deres fremstilling samt laegemidler indeholdende disse stoffer
DK571078A (da) Insekticide forbindelser fremgangsmaade til fremstilling heraf og insekticide kompositioner indeholdende disse
DK575678A (da) 5-(2-anilinoalkylamino-1-hydroxyalkyl) salicylamider fremgangsmaade til deres fremstilling samt farmaceutiske kompositioner indeholdende disse
DK218677A (da) Triazoloforbindelser fremgangsmader til deres fremstilling og til deres anvendelse og kompositioner indeholdende disse forbindelser
DK116076A (da) Oximforbindelser med anti-depressiv virkning fremgangsmade til deres fremstilling og farmaceutiske kompositioner indeholdende disse forbindelser
DK541580A (da) Fremgangsmaade til fremstilling af n-substituerede aminosyrer
DK538577A (da) Isoxaolderivater fremgangsmaade til deres fremstilling og midler indeholdende disse forbindelser
RO75224A (ro) Procedeu pentru prepararea etilaminoditiocarbamatilor n-substituiti

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment